National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 331 cases where Vaccine is HPV4 and Symptom is Death

Case Details

This is page 28 out of 34

Result pages: prev   19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 632398 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2016-04-13
Onset:2016-04-18
   Days after vaccination:5
Submitted: 2016-04-21
   Days after onset:3
Entered: 2016-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. K010050 / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Loss of consciousness, Musculoskeletal stiffness, Pyrexia, Syncope, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dystonia (broad), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2016-04-18
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1604GBR012905

Write-up: This spontaneous report was received from a Coroner''s office notification letter via company representative regarding a 13 year old female patient. Information on her concurrent conditions and medical history were not reported. On 13-APR-2016 the patient was vaccinated with GARDASIL lot # K010050, expiry date February 2017 (dose number, dose, route and anatomical location were not specified). Concomitant medication were not reported. On 13-APR-2016 night, the patient complained of a stiff neck and had mild temperature. On an unknown date in April 2016 (a couple of days later), the patient began vomiting. On 17-APR-2016, she went to hospital and was sent to home. On 18-APR-2016 the patient collapsed at home and the death was confirmed at hospital. The cause of death was not specified. Outcome of loss of consciousness, adverse event, vomiting, pyrexia and musculoskeletal stiffness was unknown at the time of reporting. On 18-APR-2016 the patient died. The cause of death was not specified. Relatedness of the events with GARDASIL was not reported. This case was linked to case# 1603GBR007278 (same reporter link). Additional information has been requested.


VAERS ID: 637627 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-05-23
Entered: 2016-05-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Skin ulcer
SMQs:, Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1605MYS010724

Write-up: This spontaneous report was received from a physician via company representative and through an unspecified reporter of an online post. The post refers to thousands of girls/women, whose current conditions and medical history was not known. The reporter of the online post stated that the GARDASIL (dosage details and lot number were not reported) was not only causing massive open sore reactions, but it was causing death right after the vaccination shot. Hence the causality of the event was considered related. Upon internal review "death" was determined to be medically significant. The case is linked to 1605MYS009128 and 1605MYS009749 (same reporter link). Additional information has been requested.


VAERS ID: 642266 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-05-31
Entered: 2016-05-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1605CAN013305

Write-up: This spontaneous report was received from a physician via company representative regarding a female patient of unknown age. The patient''s pertinent medical history and drug reactions or allergies were not reported. On an unknown date the patient was vaccinated with GARDASIL (dosage details and lot number were not reported). Concomitant medications were not reported. The physician expressed a concern since one patient informed her of a newspaper article that linked a death of a young woman due to GARDASIL vaccination on an unknown date. The cause of death was unknown. Physician would like information and reassurance on the safety of GARDASIL 4 and 9. Causality was not reported. Additional information has been requested.


VAERS ID: 644091 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-07-15
Entered: 2016-07-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Anaphylactic reaction, Death, Vaccination error
SMQs:, Anaphylactic reaction (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypersensitivity (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1607VNM004174

Write-up: This solicited information has been received from an unknown source via Company regarding 200 patients of unknown age and gender enrolled in a study. The patients'' concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patients were vaccinated with GARDASIL. There was overimmunization with GARDASIL and anaphylaxis which resulted in death of 200 patients. It was reported that anaphylaxis rate of girls who received the vaccine was much higher. It was also reported that it was 20 times higher when compared to other vaccination programs. The causality assessment of the events were not provided. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted. This is an amended report. The events anaphylaxis and overimmunization are captured with fatal outcome. The whole narrative has been updated accordingly.


VAERS ID: 645898 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-07-26
Entered: 2016-07-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1607ISR010449

Write-up: This spontaneous report as received from a physician (gynecologist) refers to a patient of unknown age and gender. The physician obtained the information from an article, which was published on the internet approximately "six month ago". Information regarding relevant medical history and concurrent condition were not reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, route and lot # not reported). Information regarding concomitant medications was not reported. The patient died as a result from GARDASIL. The date and cause of death was not specified. It was unknown whether an autopsy was performed. The physician did not remember details about what was exactly written in the article. Upon internal review, death was considered to be medically significant. Additional information has been requested.


VAERS ID: 673410 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2016-07-13
Submitted: 2016-09-07
   Days after onset:56
Entered: 2016-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Adverse event, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609VNM002838

Write-up: This solicited report was received from a social media researcher as a part of Market Research regarding an online article describing a patient of unknown age and gender. No concurrent conditions, historical conditions or concomitant therapies were reported. On an unspecified date, patient was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The article listed dangerous side effects such as increase in risk of getting cervical cancer of HPV vaccine, mentioning GARDASIL. The onset date of event was reported as 13-JUL-2016 (it was also the date of the online article publication). Doctor cited in the article ensured about the vaccine''s safety and recommended people not to believe in inauthentic sources. On an unknown date in July 2016, the patient died due to the event. The relatedness between adverse event and GARDASIL was not reported. Upon internal review, the adverse event was considered to be medically significant. Additional information is not expected because there was no consent to contact the reporter.


VAERS ID: 673415 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2016-07-13
Submitted: 2016-09-08
   Days after onset:57
Entered: 2016-09-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2016-07-13
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609VNM002772

Write-up: This solicited study report was received from an online article, as part of a marketing research program, refers to a female patient of unknown age. The patient''s medical history, concurrent condition and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL (lot number, dose and route were not provided). After getting the HPV vaccine, the patient died on 13-JUL-2016. The cause of death was unknown. It was unknown if autopsy was performed. However, this case had not been verified yet and it was also concluded that the HPV vaccine was safe and recommended for using for prevention of HPV diseases and cervical cancer. The death was determined to be a medically significant event by the reporter. This is one of several reports received from the same reporter. Additional information is not expected as the further information can not be obtained.


VAERS ID: 673432 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-09
Entered: 2016-09-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Amnesia, Arthritis, Death, Epilepsy, Headache, Myalgia, Myocardial infarction
SMQs:, Rhabdomyolysis/myopathy (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Dementia (broad), Convulsions (narrow), Embolic and thrombotic events, arterial (narrow), Noninfectious encephalopathy/delirium (broad), Eosinophilic pneumonia (broad), Generalised convulsive seizures following immunisation (narrow), Arthritis (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609VNM003100

Write-up: This solicited report was received from a social media researcher regarding an article about female patients who received HPV vaccine. The patient numbers were unknown. The patients'' concurrent conditions, medical history and concomitant medications were not reported. On an unknown date/dates the patient/patients received GARDASIL (dosing details not specified). The article indicated that patients had dangerous side effects (myocardial infarction, headache, epilepsy, memory loss, arthritis, muscle ache and death) after receiving GARDASIL vaccine (the onset date was also reported as 07-JUL-2016). The article also indicated the that the vaccine''s effect was not verified and could increase the risk of getting cervical cancer. The action taken with GARDASIL due to the events was reported as unknown. The outcome of the events myocardial infarction, headache, epilepsy, memory loss, arthritis, increased risk of cervical cancer and muscle ache was unknown. The causal relationship between the events myocardial infarction, headache, epilepsy, memory loss, arthritis, muscle ache, increased risk of cervical cancer and death with GARDASIL was unknown. Events myocardial infarction, headache, epilepsy, memory loss, arthritis, muscle ache, increased risk of cervical cancer and death with were considered medically significant. The event myocardial infarction was considered life threatening. The events headache, epilepsy, myocardial infarction, memory loss, arthritis, muscle ache were considered to causing disability. Additional information is not expected as there was not consent for contact.


VAERS ID: 673636 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-12
Entered: 2016-09-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Death, Encephalitis
SMQs:, Noninfectious encephalitis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609CHL004939

Write-up: Information has been received from a gynecologist via a company representative referring to multiple female patients of unknown age. Information regarding concomitant therapy, concurrent condition and medical history was not reported. On unknown dates, the patients were vaccinated with GARDASIL 0.5 ml injection (lot # and expiration date were not reported; 0.5ml) intramuscularly. It was reported that the patients experienced encephalitis and died (date not reported). It was unknown if autopsy was performed. The causality between encephalitis and the vaccine was unknown. Upon internal review, the event encephalitis was considered to be medically significant. Additional information has been requested.


VAERS ID: 656568 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-30
Entered: 2016-09-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609ESP014508

Write-up: Information has been received from Sanofi Pasteur MSD [ES-1577272925-2016009753] on 29-SEP-2016. Case received on 26-SEP-2016. This is a non valid case as required minimum information is missing about the patient, reporter (reporter fields have been completed to allow submission). A adolescent patient of unknown sex received GARDASIL (batch number unknown) on an unknown date. According to the information gained from internet/digital media: The information found on media was misdealing and confusing. One hand, the heading said "352 adolescents died after vaccination either with GARDASIL or CERVARIX" but, there was no information on when, where and which vaccine in each case. On the other hand, sex is not clearly defined and only adolescent group was mentioned clearly. It was reported that 352 deaths but not specified dates nor countries. There is no date of the events as well. Upon internal review, the Agency had considered an invalid case, compiling all cases as GARDASIL (although it is not stated), considering country as the case was acknowledged in country (but it is not stated if there is a single country case), reporter was not known, individual patients cannot be identified neither which HPV vaccine was used in each case. Invalid case classified following GVP Module VI. The patient''s outcome was reported as Fatal.


Result pages: prev   19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=28&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166